Name | Number of supported studies | Average coverage | |
---|---|---|---|
conventional dendritic cell | 17 studies | 26% ± 12% | |
dendritic cell | 11 studies | 30% ± 9% | |
mast cell | 10 studies | 23% ± 6% | |
renal alpha-intercalated cell | 5 studies | 47% ± 17% | |
cardiac muscle cell | 5 studies | 41% ± 10% | |
epithelial cell of proximal tubule | 4 studies | 21% ± 3% | |
adipocyte | 4 studies | 20% ± 3% | |
myeloid cell | 4 studies | 18% ± 1% | |
squamous epithelial cell | 3 studies | 26% ± 7% | |
classical monocyte | 3 studies | 31% ± 10% | |
macrophage | 3 studies | 20% ± 4% | |
GABAergic neuron | 3 studies | 28% ± 10% | |
glutamatergic neuron | 3 studies | 30% ± 12% | |
kidney distal convoluted tubule epithelial cell | 3 studies | 26% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 2935.83 | 653 / 653 | 94% | 23.91 | 566 / 605 |
kidney | 99% | 2245.82 | 88 / 89 | 94% | 20.15 | 845 / 901 |
intestine | 98% | 969.70 | 943 / 966 | 87% | 7.28 | 461 / 527 |
stomach | 98% | 1086.64 | 351 / 359 | 86% | 5.99 | 246 / 286 |
lung | 90% | 486.87 | 522 / 578 | 86% | 11.79 | 990 / 1155 |
esophagus | 78% | 444.03 | 1132 / 1445 | 86% | 10.31 | 158 / 183 |
breast | 95% | 865.79 | 434 / 459 | 68% | 4.29 | 762 / 1118 |
liver | 69% | 493.91 | 156 / 226 | 85% | 10.91 | 346 / 406 |
bladder | 90% | 564.52 | 19 / 21 | 56% | 4.46 | 283 / 504 |
uterus | 81% | 363.03 | 137 / 170 | 58% | 3.97 | 267 / 459 |
ovary | 99% | 2083.12 | 179 / 180 | 28% | 1.08 | 122 / 430 |
skin | 54% | 213.07 | 978 / 1809 | 61% | 8.43 | 288 / 472 |
muscle | 100% | 2833.59 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 1847.21 | 823 / 861 | 0% | 0 | 0 / 0 |
adipose | 94% | 1040.74 | 1127 / 1204 | 0% | 0 | 0 / 0 |
spleen | 93% | 491.06 | 223 / 241 | 0% | 0 | 0 / 0 |
pancreas | 2% | 7.81 | 8 / 328 | 86% | 7.57 | 153 / 178 |
peripheral blood | 82% | 1518.30 | 766 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 58% | 3.02 | 26 / 45 |
prostate | 22% | 73.04 | 53 / 245 | 36% | 1.56 | 180 / 502 |
adrenal gland | 5% | 23.38 | 14 / 258 | 45% | 3.51 | 104 / 230 |
brain | 30% | 145.63 | 785 / 2642 | 11% | 0.42 | 77 / 705 |
blood vessel | 35% | 167.01 | 463 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 21% | 1.42 | 6 / 29 |
eye | 0% | 0 | 0 / 0 | 4% | 0.18 | 3 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006654 | Biological process | phosphatidic acid biosynthetic process |
GO_0019432 | Biological process | triglyceride biosynthetic process |
GO_0032006 | Biological process | regulation of TOR signaling |
GO_0006072 | Biological process | glycerol-3-phosphate metabolic process |
GO_0016024 | Biological process | CDP-diacylglycerol biosynthetic process |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0004366 | Molecular function | glycerol-3-phosphate O-acyltransferase activity |
GO_0003841 | Molecular function | 1-acylglycerol-3-phosphate O-acyltransferase activity |
GO_0102420 | Molecular function | sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity |
Gene name | GPAT3 |
Protein name | Glycerol-3-phosphate acyltransferase 3 (GPAT-3) (EC 2.3.1.15) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 10) (AGPAT 10) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 9) (1-AGP acyltransferase 9) (1-AGPAT 9) (EC 2.3.1.51) (Acyl-CoA:glycerol-3-phosphate acyltransferase 3) (hGPAT3) (Lung cancer metastasis-associated protein 1) (Lysophosphatidic acid acyltransferase theta) (LPAAT-theta) (MAG-1) |
Synonyms | MAG1 HMFN0839 AGPAT9 UNQ2753/PRO6492 |
Description | FUNCTION: Converts glycerol-3-phosphate to 1-acyl-sn-glycerol-3-phosphate (lysophosphatidic acid or LPA) by incorporating an acyl moiety at the sn-1 position of the glycerol backbone . Also converts LPA into 1,2-diacyl-sn-glycerol-3-phosphate (phosphatidic acid or PA) by incorporating an acyl moiety at the sn-2 position of the glycerol backbone . Protects cells against lipotoxicity . . |
Accessions | ENST00000611707.4 ENST00000395226.6 ENST00000264409.5 Q53EU6 |